Texas A&M researchers, led by Dr. Arum Han, secured NIH funding for a new organ-on-a-chip center aimed at improving chemical safety testing and potentially reducing reliance on animal studies. The initiative is part of a $15.3 million NIH-supported center. The project ties engineering advances to translational toxicology, targeting more predictive models for how compounds affect living tissues. For drugmakers and chemical safety stakeholders, the move increases momentum for OoC platforms as inputs to risk assessment and decision-making across preclinical development and regulatory evaluation.